Supremes deny Arthrex in $85M loss to Smith & Nephew
The U.S. Supreme Court declines to hear an Arthrex appeal of its $85 million patent infringement loss to Smith & Nephew.
The U.S. Supreme Court declined to entertain an Arthrex appeal of its $85 million patent infringement loss to rival Smith & Nephew (FTSE:SN, NYSE:SNN), following a lower court's reversal of the earlier ruling.
Back in January the U.S. Court of Appeals for the Federal Circuit overturned a lower court's ruling in a lawsuit over surgical anchor patents and sent the case back for reconsideration.
In September Arthrex asked the Supremes to hear its appeal of the reversal, according to court documents. But earlier this week the high court declined, without comment, to hear the case.